These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24002934)

  • 1. Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model.
    Mittapalli RK; Liu X; Adkins CE; Nounou MI; Bohn KA; Terrell TB; Qhattal HS; Geldenhuys WJ; Palmieri D; Steeg PS; Smith QR; Lockman PR
    Mol Cancer Ther; 2013 Nov; 12(11):2389-99. PubMed ID: 24002934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
    Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
    J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
    Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer.
    Thomas FC; Taskar K; Rudraraju V; Goda S; Thorsheim HR; Gaasch JA; Mittapalli RK; Palmieri D; Steeg PS; Lockman PR; Smith QR
    Pharm Res; 2009 Nov; 26(11):2486-94. PubMed ID: 19774344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer.
    Samala R; Thorsheim HR; Goda S; Taskar K; Gril B; Steeg PS; Smith QR
    Pharm Res; 2016 Dec; 33(12):2904-2919. PubMed ID: 27541873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism.
    Galer CE; Sano D; Ghosh SC; Hah JH; Auzenne E; Hamir AN; Myers JN; Klostergaard J
    Oral Oncol; 2011 Nov; 47(11):1039-47. PubMed ID: 21903450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
    Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
    Auzenne E; Ghosh SC; Khodadadian M; Rivera B; Farquhar D; Price RE; Ravoori M; Kundra V; Freedman RS; Klostergaard J
    Neoplasia; 2007 Jun; 9(6):479-86. PubMed ID: 17603630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
    Lee SJ; Ghosh SC; Han HD; Stone RL; Bottsford-Miller J; Shen DY; Auzenne EJ; Lopez-Araujo A; Lu C; Nishimura M; Pecot CV; Zand B; Thanapprapasr D; Jennings NB; Kang Y; Huang J; Hu W; Klostergaard J; Sood AK
    Clin Cancer Res; 2012 Aug; 18(15):4114-21. PubMed ID: 22693353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
    J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.
    Lee HJ; Hanibuchi M; Kim SJ; Yu H; Kim MS; He J; Langley RR; Lehembre F; Regenass U; Fidler IJ
    Neuro Oncol; 2016 Apr; 18(4):486-96. PubMed ID: 26995790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.
    Hoffmann J; Fichtner I; Lemm M; Lienau P; Hess-Stumpp H; Rotgeri A; Hofmann B; Klar U
    Neuro Oncol; 2009 Apr; 11(2):158-66. PubMed ID: 18780814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
    Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.